These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 33720933)

  • 1. Human induced pluripotent stem cell-derived three-dimensional cardiomyocyte tissues ameliorate the rat ischemic myocardium by remodeling the extracellular matrix and cardiac protein phenotype.
    Yokoyama J; Miyagawa S; Akagi T; Akashi M; Sawa Y
    PLoS One; 2021; 16(3):e0245571. PubMed ID: 33720933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells.
    Takeda M; Miyagawa S; Fukushima S; Saito A; Ito E; Harada A; Matsuura R; Iseoka H; Sougawa N; Mochizuki-Oda N; Matsusaki M; Akashi M; Sawa Y
    Tissue Eng Part C Methods; 2018 Jan; 24(1):56-67. PubMed ID: 28967302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laminin-221 Enhances Therapeutic Effects of Human-Induced Pluripotent Stem Cell-Derived 3-Dimensional Engineered Cardiac Tissue Transplantation in a Rat Ischemic Cardiomyopathy Model.
    Samura T; Miyagawa S; Kawamura T; Fukushima S; Yokoyama JY; Takeda M; Harada A; Ohashi F; Sato-Nishiuchi R; Toyofuku T; Toda K; Sekiguchi K; Sawa Y
    J Am Heart Assoc; 2020 Aug; 9(16):e015841. PubMed ID: 32783519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
    Zhu W; Zhao M; Mattapally S; Chen S; Zhang J
    Circ Res; 2018 Jan; 122(1):88-96. PubMed ID: 29018036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.
    Wendel JS; Ye L; Tao R; Zhang J; Zhang J; Kamp TJ; Tranquillo RT
    Stem Cells Transl Med; 2015 Nov; 4(11):1324-32. PubMed ID: 26371342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.
    Lou X; Zhao M; Fan C; Fast VG; Valarmathi MT; Zhu W; Zhang J
    Cardiovasc Res; 2020 Mar; 116(3):671-685. PubMed ID: 31350544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biocompatibility of extracellular matrix hydrogel with human iPSCs differentiated cardiomyocytes].
    Fan JY; Li SL; Jiang M; Tao B; Cao RH; Zhang JB; Tian L; Liu JW; Wang HB; Cao F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 May; 49(5):487-495. PubMed ID: 34034383
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel xeno-free human heart matrix-derived three-dimensional scaffolds.
    Holt-Casper D; Theisen JM; Moreno AP; Warren M; Silva F; Grainger DW; Bull DA; Patel AN
    J Transl Med; 2015 Jun; 13():194. PubMed ID: 26084398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
    Citro L; Naidu S; Hassan F; Kuppusamy ML; Kuppusamy P; Angelos MG; Khan M
    PLoS One; 2014; 9(12):e116281. PubMed ID: 25551230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyocytes from CCND2-overexpressing human induced-pluripotent stem cells repopulate the myocardial scar in mice: A 6-month study.
    Fan C; Fast VG; Tang Y; Zhao M; Turner JF; Krishnamurthy P; Rogers JM; Valarmathi MT; Yang J; Zhu W; Zhang J
    J Mol Cell Cardiol; 2019 Dec; 137():25-33. PubMed ID: 31629738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Extracellular-Matrix Functionalization of 3D hiPSC-Based Cardiac Tissues Improves Cardiomyocyte Maturation.
    Almeida HV; Tenreiro MF; Louro AF; Abecasis B; Santinha D; Calmeiro T; Fortunato E; Ferreira L; Alves PM; Serra M
    ACS Appl Bio Mater; 2021 Feb; 4(2):1888-1899. PubMed ID: 35014458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of MG53 Enhances Cell Survival and Engraftment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Injured Hearts.
    Park KH; He X; Jiang L; Zhu H; Liang J; Wang Y; Ma J
    Stem Cell Rev Rep; 2023 Oct; 19(7):2420-2428. PubMed ID: 37477774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction.
    Tan SH; Loo SJ; Gao Y; Tao ZH; Su LP; Wang CX; Zhang SL; Mu YH; Cui YH; Abdurrachim D; Wang WH; Lalic J; Lim KC; Bu J; Tan RS; Lee TH; Zhang J; Ye L
    Theranostics; 2021; 11(16):7879-7895. PubMed ID: 34335970
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.
    Khan M; Xu Y; Hua S; Johnson J; Belevych A; Janssen PM; Gyorke S; Guan J; Angelos MG
    PLoS One; 2015; 10(5):e0126338. PubMed ID: 25993466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Treatment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates.
    Cheng YC; Hsieh ML; Lin CJ; Chang CMC; Huang CY; Puntney R; Wu Moy A; Ting CY; Herr Chan DZ; Nicholson MW; Lin PJ; Chen HC; Kim GC; Zhang J; Coonen J; Basu P; Simmons HA; Liu YW; Hacker TA; Kamp TJ; Hsieh PCH
    Circulation; 2023 Oct; 148(18):1395-1409. PubMed ID: 37732466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts.
    Guan X; Xu W; Zhang H; Wang Q; Yu J; Zhang R; Chen Y; Xia Y; Wang J; Wang D
    Stem Cell Res Ther; 2020 Feb; 11(1):73. PubMed ID: 32085809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of histamine/H
    Zhu X; Ding S; Li H; Zhang Z; Xu L; Wu J; Wang X; Zou Y; Yang X; Ge J
    Stem Cell Res Ther; 2020 Mar; 11(1):27. PubMed ID: 32127042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.
    Frangogiannis NG
    Circ Res; 2019 Jun; 125(1):117-146. PubMed ID: 31219741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure.
    Liao S; Zhang Y; Ting S; Zhen Z; Luo F; Zhu Z; Jiang Y; Sun S; Lai WH; Lian Q; Tse HF
    Stem Cell Res Ther; 2019 Mar; 10(1):78. PubMed ID: 30845990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.